Class of 2025
For vital contributions to cancer genomics and drug discovery, including codiscovering EGFR mutations in lung cancer, discovering the role of MITF as a lineage oncogene in melanoma, leading the development of the Cancer Cell Line Encyclopedia initiative, and advancing over 35 cancer therapeutics into clinical trials, effectively revolutionizing precision medicine for a diverse array of cancer types.
*Full-length biography in development